2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow SARS-CoV2 Infection: new trials by email Literature Review of SARS-CoV2 Infection trials Research Report on SARS-CoV2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs mRNA- COVID-19, Prevnar13 - SARS-CoV2 Infection, Coronavirus Infection | Phase 4 | Unknown | Mark Loeb | 414 | 2022-08-01 | 2022-06-30 |
| Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection Ivermectin Pill, Combined ART/hydroxychloroquine - Asymptomatic Infections, SARS-CoV2 Infection | Phase 4 | Unknown | Mahidol University | 80 | 2020-07-13 | 2021-01-11 |
COVID-19 (2) · Asymptomatic Infections (1) · Coronavirus Infections (1)
Coronaviridae Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Asymptomatic Diseases (1) · Coronavirus Infections (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
2019-nCoV Vaccine mRNA-1273 (1) · Ivermectin (1) · Pneumococcal Vaccines (1)
Mahidol University (1) · Mark Loeb (1)
Canada (1) · Thailand (1)
Mark Loeb, MD (1) · Yupin Suputtamongkol, MD (1)